Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-Modulated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00778908
What this trial is testing

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guangxi Medical University 120
Testing effectiveness (Phase 2)Study completedNCT02004418
What this trial is testing

Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland

Who this might be right for
Prostatic Neoplasms
AHS Cancer Control Alberta 21
Testing effectiveness (Phase 2)Looking for participantsNCT06024824
What this trial is testing

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Trials Ireland 49
Testing effectiveness (Phase 2)Study completedNCT00188513
What this trial is testing

Intensity Modulated Radiation Therapy - Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 267
Not applicableStudy completedNCT02949596
What this trial is testing

Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy

Who this might be right for
Anal CancerQuality of Life
Instituto do Cancer do Estado de São Paulo 19
Testing effectiveness (Phase 2)Study completedNCT01209442
What this trial is testing

Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Colorado, Denver 30
Large-scale testing (Phase 3)Looking for participantsNCT04136886
What this trial is testing

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 346
Not applicableEnded earlyNCT00350688
What this trial is testing

Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy

Who this might be right for
Bladder Cancer
Ottawa Hospital Research Institute 9
Testing effectiveness (Phase 2)Study completedNCT03521570
What this trial is testing

Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Emory University 62
Not applicableUnknownNCT02456506
What this trial is testing

Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal NeoplasmsMortalityQuality of Life+1 more
Sun Yat-sen University 142
Testing effectiveness (Phase 2)Looking for participantsNCT07470606
What this trial is testing

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Who this might be right for
Brain Tumor
The University of Texas Health Science Center at San Antonio 108
Testing effectiveness (Phase 2)Looking for participantsNCT06971211
What this trial is testing

Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Jianbin Bi 40
Testing effectiveness (Phase 2)UnknownNCT04547621
What this trial is testing

HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Who this might be right for
Glioma, Malignant
Huashan Hospital 50
Not applicableStudy completedNCT00323466
What this trial is testing

The Effect on Oro-dental Complications of Intensity Modulated Radiotherapy (IMRT) Versus Conventional Radiotherapy in Patients With Cancer of the Head or Neck

Who this might be right for
Cancer: Head or Neck
University Hospital, Ghent 43
Large-scale testing (Phase 3)Study completedNCT00062309
What this trial is testing

Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 307
Not applicableStudy completedNCT02860234
What this trial is testing

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 68
Testing effectiveness (Phase 2)Study completedNCT00593866
What this trial is testing

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Michigan Rogel Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT02913066
What this trial is testing

S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Mianyang Central Hospital 88
Testing effectiveness (Phase 2)Study completedNCT00408694
What this trial is testing

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Who this might be right for
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7+2 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT02979691
What this trial is testing

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Who this might be right for
Esophagus CancerEsophagogastric Junction CancerRadiotherapy; Complications+1 more
Chinese Academy of Medical Sciences 350
Next Page
46